DeutschNewstral
Article
bizjournals.com on 2021-04-15 20:18
Bristol Myers Squibb expands local footprint at Cambridge Crossing
Related news
- LMassBio Recognizes Eascra Biotech, Vertex Pharmaceuticals and Bristol Myers Squibblionessmagazine.com
- MBristol Myers Squibb to purchase Karuna Therapeuticsmvtelegraph.com
- BBristol Myers Squibb Reports Earnings Tomorrowbarrons.com
- Bristol Myers Squibb expanding cell manufacturing in Devensbizjournals.com
- Immatics inks $920M licensing deal with Bristol Myers Squibbbizjournals.com
- UMB sues Bristol Myers Squibb over slowed approval of cancer treatment Breyanzibizjournals.com
- BBristol Myers Squibb Beats Earnings Estimates, but Shares Fall1 min readbarrons.com
Bristol Myers Squibb warns US price reforms will dent drug developmentFinancial Times- Century Therapeutics shares soar on potential multibillion-dollar deal with Bristol Myers Squibbbizjournals.com
Bristol Myers Squibb buys San Diego cancer therapy company for $4.8BMerced Sun-Star- MBluebird, Bristol-Myers Squibb have resubmit FDA bid for CAR-T therapymarketwatch.com
- BBristol Myers Squibb Beats Earnings Estimates, but Shares Fall2 min readbarrons.com
Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, CernerForbes- 40 Under 40 Class of 2021: Miranda Broz, Bristol Myers Squibbbizjournals.com
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolioSeattle Times- FBristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharmaft.com
- Bristol-Myers Squibb to open Cambridge R&D centerbizjournals.com
- Why Bristol Myers Squibb Is A Top Socially Responsible Dividend StockForbes
- Bristol Myers Squibb grant to Roswell Park expands Native American cancer servicesbizjournals.com